BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34023162)

  • 1. Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44.
    Pfister D; Hartmann F; Heidenreich A
    Eur Urol; 2021 Aug; 80(2):e61. PubMed ID: 34023162
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44.
    Torricelli FCM; Coelho RF
    Eur Urol; 2021 Aug; 80(2):e57. PubMed ID: 34099342
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Fabio C.M. Torricelli and Rafael F. Coelho's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44.
    Knipper S; Maurer T
    Eur Urol; 2021 Aug; 80(2):e58. PubMed ID: 34078552
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44: Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
    Montorsi F; Fossati N; Bravi CA; Gandaglia G; Suardi N; Briganti A
    Eur Urol; 2021 May; 79(5):e132-e133. PubMed ID: 33579576
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
    Knipper S; Maurer T
    Eur Urol; 2021 May; 79(5):e134. PubMed ID: 33579574
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery. Eur Urol 2022;83:62-9.
    Pontes-Silva A
    Eur Urol; 2023 May; 83(5):e139. PubMed ID: 36797142
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. Eur Urol 2016;70:588-96: Testing the Utility of Genomic Scores in the Setting of Recurrent Prostate Cancer After Radical Prostatectomy: We Can Certainly Do Better.
    Fossati N; Gandaglia G; Bossi A; Montorsi F; Briganti A
    Eur Urol; 2016 Oct; 70(4):e108-e109. PubMed ID: 26992282
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27-30: Salvage Robotic Radical Prostatectomy for Recurrent Prostate Cancer After Focal Therapy.
    Marra G; Van Velthoven R; Valerio M
    Eur Urol; 2020 Apr; 77(4):e103-e104. PubMed ID: 31607392
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
    Chin JL
    Eur Urol; 2018 May; 73(5):808. PubMed ID: 29275832
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Pietro Piazza, Luca Sarchi, Stefano Puliatti, Carlo Andrea Bravi, Sophie Knipper, Alexandre Mottrie. The Unsolved Issue of Reporting of Late Complications in Urology. Eur Urol 2021;80:527-528.
    Sathianathen NJ; Lawrentschuk N; Furrer MA
    Eur Urol; 2022 Jan; 81(1):e11-e12. PubMed ID: 34742586
    [No Abstract]   [Full Text] [Related]  

  • 11. Salvage Treatment After Radical Prostatectomy.
    Parker C; Sydes MR
    Eur Urol; 2018 Feb; 73(2):166-167. PubMed ID: 28779975
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Patrick C. Walsh, Nathan Lawrentschuk. Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins. Eur Urol 2016;69:191-2: Personalization of Immediate Adjuvant Radiation Therapy in Prostate Cancer Does Not Mean Omission.
    Alongi F; Mazzola R; Fersino S
    Eur Urol; 2016 Dec; 70(6):e160-e161. PubMed ID: 27209540
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Jae Heon Kim, Bora Lee, and Benjamin I. Chung's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50.
    Mandel P; Tilki D
    Eur Urol; 2017 Dec; 72(6):e176. PubMed ID: 28709729
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Marc Furrer, Niranjan J. Sathianathen, and Nathan Lawrentschuk's Letter to the Editor re: Pietro Piazza, Luca Sarchi, Stefano Puliatti, Carlo Andrea Bravi, Sophie Knipper, Alexandre Mottrie. The Unsolved Issue of Reporting of Late Complications in Urology. Eur Urol 2021;80:527-528.
    Piazza P; Sarchi L; Puliatti S; Mottrie A
    Eur Urol; 2022 Jan; 81(1):e13. PubMed ID: 34742585
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Daher C. Chade, Shahrokh F. Shariat, Angel M. Cronin, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur urol 2011;60:205-10.
    Qin X; Ye D
    Eur Urol; 2011 Oct; 60(4):e34. PubMed ID: 21764210
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7. Re: Ronald C. Chen. Postprostatectomy Radiotherapy: Whether and How Long to Give Concurrent Androgen Deprivation Therapy. Eur Urol 2016;69:58-9: Which patients need treatment intensification?
    Dal Pra A; Spahn M
    Eur Urol; 2016 Apr; 69(4):e74-e75. PubMed ID: 26508311
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
    Achard V; Dal Pra A; Zilli T
    Eur Urol; 2020 Dec; 78(6):e221-e222. PubMed ID: 33008661
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence.
    Wymer KM; Sharma V; Davis BJ; Kwon ED; Mynderse LA; Karnes RJ
    Clin Genitourin Cancer; 2019 Jun; 17(3):e536-e540. PubMed ID: 30902522
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply from authors re: Guillaume Ploussard, James W. Catto. The quest for an optimal definition of prostate-specific antigen failure following radical prostatectomy: the risk of not seeing the forest for the trees. Eur Urol 2014;66:211-13: Identifying the candidates for early salvage therapy after radical prostatectomy.
    Mir MC; Stephenson AJ
    Eur Urol; 2014 Aug; 66(2):213. PubMed ID: 24176596
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14.
    Montorsi F; Fossati N; Gandaglia G; Briganti A
    Eur Urol; 2020 Apr; 77(4):e107. PubMed ID: 31980310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.